Bay City Capital LLC has bought stock on 3 days since Jan 2016

Bay City Capital LLC is a life sciences investment firm and venture capital company, not an individual insider.( Founded in 1997, the privately held firm focuses on investments across the life sciences sector, including biopharmaceuticals, medical devices, diagnostics, healthcare IT, nutrition, and agribusiness, with a diversified strategy ranging from seed-stage to public companies.( Headquartered in the San Francisco Bay Area, with offices in the United States and Switzerland, Bay City Capital has raised approximately $1.3 billion across five venture capital funds and has invested in more than 100 companies worldwide.(

Bay City Capital’s business operations center on managing general life sciences funds and strategic relationships, combining financial, operational, and scientific expertise with active board participation to support portfolio company growth and liquidity events.( The firm is led by Founder and Managing Director Fred Craves, PhD, who has built Bay City Capital into a premier global life science investment platform, alongside other managing directors such as David Beier, JD, and a professional staff and advisory team based primarily in San Francisco.( Over its history, Bay City Capital has been associated with notable exits and public-market successes in biopharmaceuticals and related sectors, reinforcing its role as a significant institutional investor and corporate insider in companies such as Xilio Therapeutics, Inc. (XLO).(

Written by Perplexity from public sources.